Home / Inspections / 580664

FDA Inspection 580664 — Octapharma AB

Octapharma AB — FEI 3005559915

The FDA completed an inspection of Octapharma AB on January 29, 2009 in Stockholm. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 29, 2009
Fiscal Year
2009
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Stockholm (Sweden)

Facility

Other inspections at this facility

  • 1218250 (VAI Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1070173 (VAI Fri Sep 28 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 894095 (VAI Mon Apr 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 783783 (VAI Thu Jan 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 710676 (OAI Thu Jan 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources